CARsgen Therapeutics Holdings Limited (2171.HK)

HKD 14.98

(1.22%)

Net Income Summary of CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Limited's latest annual net income in 2023 was -747.79 Million CNY , up 16.19% from previous year.
CARsgen Therapeutics Holdings Limited's latest quarterly net income in 2024 Q2 was - CNY , down 0.0% from previous quarter.
CARsgen Therapeutics Holdings Limited reported an annual net income of -892.24 Million CNY in 2022, up 81.19% from previous year.
CARsgen Therapeutics Holdings Limited reported an annual net income of -4.74 Billion CNY in 2021, down -163.31% from previous year.
CARsgen Therapeutics Holdings Limited reported a quarterly net income of - CNY for 2024 Q1, up 100.0% from previous quarter.
CARsgen Therapeutics Holdings Limited reported a quarterly net income of -202.23 Thousand CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Historical Annual Net Income of CARsgen Therapeutics Holdings Limited (2023 - 2019)

Year	Net Income	Net Income Growth
2023	-747.79 Million CNY	16.19%
2022	-892.24 Million CNY	81.19%
2021	-4.74 Billion CNY	-163.31%
2020	-1.8 Billion CNY	-492.13%
2019	-304.29 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	- CNY	0.0%
2024 Q1	- CNY	100.0%
2023 Q2	-202.23 Thousand CNY	0.0%
2023 FY	-747.79 Million CNY	16.19%
2023 Q3	-171.66 Thousand CNY	15.12%
2023 Q1	-202.23 Thousand CNY	21.6%
2023 Q4	-171.66 Thousand CNY	0.0%
2022 FY	-892.24 Million CNY	81.19%
2022 Q2	-188.16 Thousand CNY	0.0%
2022 Q1	-188.16 Thousand CNY	-7.35%
2022 Q3	-257.95 Thousand CNY	-37.09%
2022 Q4	-257.95 Thousand CNY	0.0%
2021 Q2	-2.19 Million CNY	0.0%
2021 Q4	-175.28 Thousand CNY	0.0%
2021 Q3	-175.28 Thousand CNY	92.02%
2021 Q1	-2.19 Million CNY	-739.79%
2021 FY	-4.74 Billion CNY	-163.31%
2020 Q4	-261.6 Thousand CNY	0.0%
2020 FY	-1.8 Billion CNY	-492.13%
2020 Q2	-270.42 Thousand CNY	0.0%
2020 Q1	-270.42 Thousand CNY	0.0%
2020 Q3	-261.6 Thousand CNY	3.26%
2019 FY	-304.29 Million CNY	0.0%

Peer Net Income Comparison of CARsgen Therapeutics Holdings Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	1155.074%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	4435.038%